Maintenance of the complex phenotype of primary hepatocytes in vitro represents a limitation for developing liver support systems and reliable tools for biomedical research and drug screening. We herein aimed at developing a biosystem able to preserve human and rodent hepatocytes phenotype in vitro based on the main characteristics of the liver sinusoid: unique cellular architecture, endothelial biodynamic stimulation, and parenchymal zonation. Primary hepatocytes and liver sinusoidal endothelial cells (LSEC) were isolated from control and cirrhotic human or control rat livers and cultured in conventional in vitro platforms or within our liverresembling device. Hepatocytes phenotype, function, and response to hepatotoxic drugs were analyzed. Results evidenced that mimicking the in vivo sinusoidal environment within our biosystem, primary human and rat hepatocytes cocultured with functional LSEC maintained morphology and showed high albumin and urea production, enhanced cytochrome P450 family 3 subfamily A member 4 (CYP3A4) activity, and maintained expression of hepatocyte nuclear factor 4 alpha (hnf4α) and transporters, showing delayed hepatocyte dedifferentiation. In addition, differentiated hepatocytes cultured within this liver-resembling device responded to acute treatment with known hepatotoxic drugs significantly different from those seen in conventional culture platforms. In conclusion, this study describes a new bioengineered device that mimics the human sinusoid in vitro, representing a novel method to study liver diseases and toxicology.
| INTRODUCTION
Primary hepatocytes are highly specialized cells used as the main tool for assessing hepatotoxicity, cellular transplantation, biomedical research, and as an essential component of active bioartificial devices to support liver function (Baccarani et al., 2004; Godoy et al., 2013; Nicolas et al., 2017) . Nevertheless, specific functions and differentiated phenotype are progressively lost when hepatocytes are cultured in vitro, leading to loss of enzymatic activity and detoxification capacity, changes in cell morphology and function, and deregulation of transporters expression (Elaut et al., 2006; Rowe et al., 2010) . Several approaches have been proposed to overcome/delay this dedifferentiation process, including sandwich cultures, spheroid systems, or the development of sinusoidal-mimicking devices known as liver-on-a-chip (Fraczek, Bolleyn, Vanhaecke, Rogiers, & Vinken, 2013; Lauschke, Hendriks, Bell, Andersson, & Ingelman-Sundberg, 2016 ).
Liver-on-a-chip are usually low-volume miniaturized devices that enable the culture of hepatic cells in different configurations both under flow or static conditions. In a healthy liver, hepatocyte functions are partially maintained by microenvironmental signaling from neighboring cells; for this reason, hepatocytes within these liver-resembling devices are often studied in coculture with nonparenchymal cells. Liver sinusoidal endothelial cells (LSEC), hepatic macrophages, and hepatic stellate cells constitute the major populations of nonparenchymal cells in the liver (Arias et al., 2009; Wisse et al., 1996) . They play central roles both in liver physiology and pathology, and therefore cannot be ignored to generate reliable coculture systems (Marrone, Shah, & Gracia-Sancho, 2016; Usta et al., 2015) , and to guarantee a greater translational capability in studies using human liver cells.
Considering the above-mentioned background, the design, development, and future applicability of a liver-on-a-chip device requires accurate selection of the hepatic cell type to be cultured, as well as the internal and external environmental stimuli that will modulate the phenotype of hosted cells (Fraczek et al., 2013) .
Although several authors used immortalized human cell lines to substitute fresh hepatocytes within their microfluidic devices (Bavli et al., 2016; Ma et al., 2016; Rennert et al., 2015) these lack a significant part of liver-specific functions (Kanebratt & Andersson, 2008; Wilkening, Stahl, & Bader, 2003) . Regarding the microenvironment modulating hepatocytes phenotype, in nature parenchymal cells are partly maintained through paracrine communication from LSEC. Indeed, the key role of LSEC in the liver has been patent not only for being the first cells sensing liver injury (Hide et al., 2016; McCuskey, 2006) but also for maintaining and enhancing hepatocytes phenotype (Bhatia, Balis, Yarmush, & Toner, 1999; Kasuya, Sudo, Mitaka, Ikeda, & Tanishita, 2011; Liu, Li, Yan, Wei, & Li, 2014; Marrone et al., 2016) . In the specific field of liver-on-a-chip, LSEC have been questionably replaced by general endothelial cells, such as human aortic endothelial cells (HAEC) (Ma et al., 2016) , human umbilical vein endothelial cells (HUVEC) (H. ; J. W. Rennert et al., 2015) , stable human endothelial cell line (EA.hy926) (Prodanov et al., 2016) or BAEC (Kang et al., 2015) among others. However, primary LSEC are rarely found in this context, especially when using human liver cells.
We hypothesized that maintaining a physiological sinusoid-like environment allowing the paracrine communication between hepatocytes and functional LSEC would provide a suitable milieu for maintaining the phenotype and function of these cells, delaying hepatocyte dedifferentiation, and being more sensitive in predicting hepatotoxicity than conventional two-dimensional in vitro cultures.
To test this hypothesis, and mainly focusing on its translational applicability, the primary aim of our study was to cautiously characterize the phenotype and function of primary human hepatocytes cocultured with primary functional human LSEC within a fluidic device that mimics the hepatic sinusoid (Illa et al., 2014) and compare with conventional configurations. In addition, and as a secondary aim, we studied this liver-on-a-chip as a potential tool for preclinical research on the fields of chronic liver disease and hepatotoxicity.
Supplementary experiments using primary rat cells were performed to endorse the model in a non-human experimental scenario. Hepatocytes and LSEC were isolated using standardized protocols (Gracia-Sancho et al., 2007; Oie, Snapkov, Elvevold, Sveinbjornsson, & Smedsrod, 2016) and cultured as detailed in Supporting Information Materials. Highly pure and viable cells were used. Cell density under each individual experimental condition was 10 6 hepatocytes and 2.5·10 5 LSEC.
| MATERIALS AND METHODS

| Isolation of human and rat hepatocytes and LSEC
2.2 | Liver-on-a-chip technology and culture of primary cells
Our team has recently developed a fluidic device whose detailed fabrication and features were previously described in Illa et al. (2014) and is herein termed Exoliver. Briefly, it consists of a sinusoidalmimicking layered structure that allows coculture of different cell assay were performed under all experimental conditions mentioned above, as described in Supporting Information Methods.
Once concluded that there were no significant differences in the studied markers between conventional mono-and coculture configurations, we decided to eliminate the conventional coculture condition in the 7-day human experiments to maximize cell seeding under the other conditions obtained from the scarce liver tissue available after surgery.
| Statistics and data analyses
Statistical analysis was performed with SPSS Statistics19 software for Windows. Results were expressed as mean ± standard error of mean. To assess differences between groups, we performed one-way analysis of variance with least significant difference (LSD) post-hoc tests when variables were parametric and Mann-Whitney test for nonparametric variables. Differences between groups were considered as significant when p value ≤ 0.05. Each experiment was performed in duplicate from at least n = 3 independent isolations.
3 | RESULTS
| Exoliver maintains human hepatocyte phenotype and function
Maintenance of human healthy hepatocytes phenotype was assessed shear stress (which leads to LSEC dysfunction Supporting Information Figure 1 ) and hepatocytes monoculture with indirect flow stimulus (without paracrine interactions from LSEC).
Synthetic capacity of hepatocytes was evaluated as active albumin and urea production and release to the culture media.
Human primary hepatocytes cultured under the Exoliver dynamic coculture condition showed higher albumin synthesis when compared with all static conditions after 3 days (Figure 2a ) and to a lesser extent after 7 days (Figure 2d ) of culture. Hepatocytes cultured using
Exoliver dynamic monoculture configuration produced higher albumin than static configurations after 3 days, but this was no longer seen after 7 days of culture. At 3 days of culture, urea production was highly increased in dynamic coculture configurations and partially maintained by dynamic monoculture condition (Figure 2a ).
At 7 days of culture (Figure 2d ), both dynamic conditions showed increased urea production compared with all static configurations.
Primary human hepatocytes in coculture with shear stressstimulated LSEC inside Exoliver showed superior cytochrome P450 family 3 subfamily A member 4 (CYP3A4) activity compared with all culture conditions both after 3 and 7 days of culture ( Figure 2b ,e, respectively). Although CYP3A4 activity in the dynamic monoculture configuration was partially increased after 3 days of culture, this maintenance was no longer significantly different after 7 days of culture, reinforcing the concept of maintenance of hepatocyte function through paracrine interactions from functional LSEC in the dynamic coculture condition.
Hepatocytes phenotype was further assessed by means of expression of the master regulator hepatocyte nuclear factor 4 alpha (hnf4α), and the transporters ATP-binding cassette subfamily C member 3 (abcc3) and solute carrier family 22 member 1 (slc22a1).
hnf4α messenger RNA (mRNA) expression was increased under
Exoliver dynamic coculture condition after 3 days (Figure 2c) although prevention of its downregulation was not reached after 7 days of culture (Figure 2f ). Results derived from slc22a1 analyses showed no significant differences in any analyzed group at 3 days of study but exhibited higher expression of this marker under Exoliver dynamic coculture condition compared with suboptimal Exoliver configurations after 7 days of culture. Abcc3 mRNA upregulation was prevented under all dynamic Exoliver conditions after 3 and 7 days of culture compared with conventional culture configurations.
Conventional configurations showed no significant differences in any of the studied parameters neither after 3 days nor 7 days of culture.
Maintenance of hepatocytes phenotype using this liver-on-a-chip device was confirmed in a second species. Supporting Information Figure 2 shows all data regarding coculture of rat primary hepatocytes and LSEC.
| Exoliver prevents hepatocytes morphology deterioration
Primary human or rat hepatocytes cultured in the previously described conditions exhibited different morphology. The characteristic polygonal shape and angular edges from freshly isolated hepatocytes were gradually lost upon culture in conventional platforms. As shown in Figure 3 , hepatocytes became flattened with diffuse separation between cells (Day 3), further acquiring myofibroblast-like morphology, finally leading to cell aggregation in clusters (Day 7). Prevention of the in vitro dedifferentiation process in the optimal Exoliver configuration was associated with maintenance of hepatocyte polygonal shape both after 3 and 7 days of culture. Suboptimal Exoliver configurations did not maintain hepatocyte morphology (Supporting Information Figure 3) . Considering all the collected data, translational experiments of the device were performed using the optimal configuration of the device and compared with conventional cell culture method.
| Exoliver as a tool to study chronic liver disease
Primary hepatocytes isolated from human cirrhotic livers and cultured in the optimal Exoliver configuration (dynamic coculture with functional LSEC) exhibited significantly better-preserved phenotype in comparison with cells in monoculture using two-dimensional conventional methods (Figure 4 ). Indeed, albumin and urea production and secretion to the culture media was significantly higher in Exoliver-cultured hepatocytes. Moreover, lower mRNA expression of the transporter abcc3 and higher mRNA expression of the transporter slc22a1 were found in hepatocytes cultured using the device, suggesting an overall maintenance of hepatocyte phenotype.
| Exoliver as a tool to study hepatotoxicity
Human hepatocytes toxicity response was assessed using acute overdose of the anti-diabetic drug troglitazone, the catechol-Oinhibitor for Parkinson's disease tolcapone, the nonsteroideal antiinflammatory drug diclofenac, and the widely prescribed anti-pyretic and analgesic drug acetaminophen.
Hepatotoxic effect of troglitazone (Figure 5a ) was demonstrated in hepatocytes cultured in the conventional two-dimensional configuration; however, it showed no toxic effect on hepatocytes cultured using Exoliver, as demonstrated by the vehicle-comparable production of the five parameters analyzed. Tolcapone-derived hepatotoxicity in two-dimensional cultured hepatocytes was shown as high transaminases release to the culture media ( Figure 5b ) although no significant effect was detected in albumin and urea production in response to acute treatment with this drug. Hepatotoxicity derived from tolcapone treatment was not seen in Exoliver-cultured hepatocytes, showing vehicle-production urea and transaminases and a significant increase in albumin synthesis.
High doses of diclofenac showed toxic effects on hepatocytes ( Figure 5c ) in conventional cultures as well as in Exoliver-cultured hepatocytes. Although no significant changes were observed in active urea and albumin synthesis, transaminases were significantly increased in response to acute treatment with this drug.
F I G U R E 2 Evaluation of healthy primary human hepatocytes after 3 days (a-c) or 7 days (d-f) of culture under the experimental conditions described in Figure 1 . Synthetic capacity of hepatocytes was measured as albumin and urea secretion, phase I enzymes detoxification capacity as cytochrome P450 family 3 subfamily A member 4 (CYP3A4) activity and cell phenotype markers as gene expression of the transcription factor hepatocyte nuclear factor 4 alpha (hnf4α), solute carrier family 22 member 1 (slc22a1), and ATP-binding cassette subfamily C member 3 (abcc3) transporters. Data derive from n = 4 independent experiments were normalized to conventional monoculture condition (fold change of 1) and expressed as mean ± standard error of the mean. To further study the applicability of Exoliver assessing hepatotoxicity, the effects of 7-day treatment with tolcapone were analyzed. 
| DISCUSSION
The current study demonstrates for the first time that it is possible to maintain primary human hepatocytes in vitro when cocultured with functional primary LSEC in a sinusoidal-like milieu. The study has been developed using a liver-resembling device that mimics the F I G U R E 4 Assessment of cirrhotic primary human hepatocytes after 3 days of culture in conventional monoculture or dynamic coculture using Exoliver. Synthetic capacity of hepatocytes was measured as albumin and urea secretion and cell phenotype markers as gene expression of the transcription factor hnf4α, slc22a1, and abcc3. Data derive from n = 4 independent experiments were normalized to conventional monoculture condition (fold change of 1) and expressed as mean ± standard error of the mean. *p value < 0.05 versus conventional culture. ExL: Exoliver F I G U R E 3 Primary healthy human and rat hepatocytes morphology after culture for 3 or 7 days in conventional monoculture or Exoliver optimal configuration. Images were taken at 10× magnification [Color figure can be viewed at wileyonlinelibrary.com] F I G U R E 5 Exoliver-cultured hepatocytes response to acute drug-induced injury. Hepatocytes viability was assessed as urea and albumin synthesis and transaminases and LDH release to the culture media. Healthy human hepatocytes were cultured in the optimal Exoliver configuration (with LSEC) or in conventional monoculture. After 24 hr of culture, hepatocytes received acute toxic insult and were cultured for additional 24 hr with 100 μM troglitazone (a), 100 μM tolcapone (b), 1 mM diclofenac (c), or 40 mM acetaminophen (d). Cell morphology (e) and release of cell death markers (soluble keratin 18 and caspase-cleaved keratin 18) (f,g) were analyzed. Images were taken at 10x magnification. Data derived from n = 4 independent experiments were normalized to vehicle concentration (fold change of 1) and expressed as mean ± standard error of the mean. *p value < 0.05 versus its corresponding vehicle. ALT: alanine aminotransferase; AST: aspartate aminotransferase; ExL: Exoliver; K18: keratin 18; LDH: lactate dehydrogenase; LSEC: liver sinusoidal endothelial cells [Color figure can be viewed at wileyonlinelibrary.com] unique architecture of the liver sinusoid allowing layered coculture of multiple cell types with controlled endothelial shear stress stimulation and paracrine communications, as it occurs in the human liver.
We herein demonstrate that the benefits of this coculture system rely on the presence of functional LSEC. Indeed, the device benefits are mainly lost in both suboptimal Exoliver configurations: a perfused monoculture of hepatocytes or coculture of cells without biomechanical stimulation. In the first scenario, and although indirect flow stimulation per se might exert some beneficial effects on hepatocytes (Dash et al., 2013; Kang et al., 2015; Rashidi, Alhaque, Szkolnicka, Flint, & Hay, 2016) , we observed that this configuration was inferior to the coculture of hepatocytes with flow-stimulated LSEC. In the second situation, hepatocytes phenotype was lost in the absence of endothelial shear stress probably due to LSEC dedifferentiation upon isolation and in vitro culture (March, Hui, Underhill, Khetani, & Bhatia, 2009 ).
However, our investigations demonstrate that LSEC functional phenotype can be efficiently maintained under dynamic culture (Marrone et al., 2013; Shah et al., 1997) , ultimately leading to hepatocytes maintenance (Dash et al., 2013) . Underlying mechanisms of such protection may derive from the fact that LSEC cultured in static configurations become rapidly dysfunctional, driving molecular signaling to hepatocytes that ultimately promote, or at least do not prevent, their dedifferentiation. In addition, functional LSEC might release soluble factors or membrane-embedded entities that contribute to maintain hepatocyte phenotype (Ding et al., 2010; Hu et al., 2014; Koch et al., 2017) . In fact, upregulation of hepcidin/hamp in Exoliver cocultured hepatocytes (Supporting Information Figure 1D ) supports angiocrine communication from functional LSEC. We cannot discard that future designs of the device, in which direct contact interactions between cells may be allowed as it occurs in the sinusoids, would give superior beneficial results than those herein described.
Interestingly, and most likely due to the singular design of the device, a relative gradient in oxygen along the culture area was observed (Supporting Information Figure 5A ). Specialization of liver cells along the portal triad-central vein axis is known as zonation, and major drivers for such compartmentalization include nutrients, hormones, and growth factors, but specially oxygen. Because zonation directly affects macronutrient metabolism, morphology, and xenobiotic transformation in hepatocytes, oxygen gradient could indeed contribute to better reproduce the sinusoidal milieu and therefore to the maintenance of hepatocytes in the device (Kietzmann, 2017) . Importantly, Exoliver-cultured hepatocytes at the inflow area were enriched in genes predominantly expressed in periportal areas of the human liver, whereas hepatocytes at the outflow predominantly expressed pericentral typical genes (McEnerney et al., 2017; Figure 5b,c) .
Considering the beneficial effects of this biosystem in preserving the phenotype of healthy human hepatocytes, we subsequently aimed at demonstrating its translational potential in two clinically relevant areas. We are aware that our study has limitations; probably the most important is that our device does not entirely recapitulate the diversity of cells found in the liver sinusoid. Adding extra cell layers, with hepatic stellate cells and/or macrophages, would probably increase its biological resemblance. Nevertheless, our data show that adding perfused LSEC per se is able to maintain hepatocytes phenotype, suggesting that LSEC play a major role in hepatocyte homeostasis.
It is true that future perspectives on liver bioengineering research are set in generating improved in vitro culture systems for modeling human diseases and performing valuable assays. The development of in vitro devices that address systemic human biology using liver-resembling devices in combination with other organ biosystems is highly needed (Coppeta et al., 2017; Maschmeyer et al., 2015) . The herein described platform may contribute to create these body-on-a-chip structures that will ultimately allow a global understanding of prodrugs and metabolites' effects in various organs.
To sum up, our study describes a novel bioengineered device that resembles the human liver in vitro, currently representing the preclinical setup closest to the bedside. Altogether encourages its applicability for the study of liver diseases and toxicology.
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